stella
beta
Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma — Stella
Recruiting
Back to Acral Melanoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Beijing Cancer Hospital, Beijing
View full record on ClinicalTrials.gov